M

$MIRM

2 articles found
0 positive
0 negative
2 neutral
The Motley FoolThe Motley Fool··Jonathan Ponciano

Boone Capital Exits 372% Biotech Winner to Chase Emerging Clinical Plays

Boone Capital liquidates entire $13.57M Cogent Biosciences stake despite 372% gain, reallocating to earlier-stage biotech plays like TYRA. Strategic rebalancing in volatile sector.
MDTTYRAIONSCOGTBMRN+2biotechclinical-stage
GlobeNewswire Inc.GlobeNewswire Inc.··Na

XOMA Royalty Surges on 68% Royalty Growth and Aggressive Portfolio Expansion

XOMA Royalty reports $50M+ cash receipts in 2025, with royalties up 68% YoY. Company adds 22 assets, completes seven acquisitions, and repurchases $16M in shares.
DAWNRZLTGOSSZVRAMIRM+3acquisitionsshare buyback